• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Floorstocks Releases Exclusive Nasdaq MarketSite Interview with Wellgistics Health Inc. (NASDAQ: WGRX)

    7/10/25 11:46:00 AM ET
    $WGRX
    Other Pharmaceuticals
    Health Care
    Get the next $WGRX alert in real time by email

    NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Floorstocks, a financial media platform with over 1.2 million active retail investors, has released an exclusive CEO interview filmed at the Nasdaq MarketSite with Brian Norton, CEO of Wellgistics Health Inc. (NASDAQ:WGRX). The full interview is now available on YouTube and Floorstocks.com, offering investors a front-row look at one of healthcare's most disruptive emerging growth companies.

    Watch the full interview on YouTube:

    https://youtu.be/gJJlbqd7Mv8

    Also streaming at Floorstocks.com:

    https://www.floorstocks.com

    Hosted by market veteran Kenneth Polcari, the interview unpacks how Wellgistics is modernizing the $600+ billion U.S. prescription drug market—eliminating intermediaries, restoring transparency, and enabling faster, compliant fulfillment from manufacturer to patient.

    "This is the kind of story our audience responds to—real revenue, strong leadership, and a disruptive path forward," said Richard Davis, CEO of Floorstocks. "The Wellgistics message is timely, clear, and rooted in solving systemic inefficiencies that the market can no longer ignore."

    The conversation highlights Wellgistics' vertically integrated tech stack, growing national footprint, and its AI-powered infrastructure supporting pharmacies, providers, manufacturers, and employer groups.

    "We appreciated the opportunity to speak directly to the investor community through Floorstocks," said Brian Norton, CEO of Wellgistics Health. "They have our full permission to distribute, quote, and promote this interview. We believe transparency builds trust—and this conversation lays out our vision clearly: fixing a broken system with scalable solutions built for today's healthcare challenges."

    This feature is part of a larger investor education campaign aimed at bringing institutional visibility to Wellgistics Health as it scales its direct distribution network, expands employer carve-out programs, and doubles down on compliant, tech-enabled pharmacy solutions.

    About Floorstocks

    Floorstocks is a financial media platform connecting high-growth public companies with the next generation of investors. Through exclusive interviews, omnichannel storytelling, and high-impact distribution across YouTube, X (Twitter), Instagram, TikTok, and email, Floorstocks is redefining how public markets are explained to the modern investor. Learn more at www.floorstocks.com.

    About Wellgistics Health Inc (NASDAQ:WGRX)

    Wellgistics Health moves medications from maker to taker—faster, cheaper, and smarter. Its platform spans wholesale distribution, digital script routing, and hub services like eligibility, prior authorization, adherence, and direct-to-patient fulfillment. A PBM alternative—but PBM-agnostic—WGRX empowers manufacturers, providers, pharmacies, and employer groups with transparent, end-to-end medication access.

    Media Contact

    Richard Davis

    Chief Executive Officer, Floorstocks

    [email protected]

    (212) 555-0192

    www.floorstocks.com

    Disclaimer: Floorstocks Inc. was engaged by Wellgistics Health Inc. (WGRX) for a paid investor awareness campaign valued at $75,000. This communication is for informational purposes only and does not constitute investment advice or a solicitation to buy or sell any security.

    • Floorstocks Inc. was compensated $75,000 by Wellgistics Health Inc. (NASDAQ:WGRX) for this investor awareness campaign. All content was independently produced and distributed under full editorial control by Floorstocks.

    • Floorstocks interviews are conducted by financial media professionals with backgrounds in capital markets, including Kenneth Polcari (former NYSE floor trader and CNBC contributor).

    • For high-resolution images, video clips, or interview segments for media coverage, contact: [email protected]



    Get the next $WGRX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WGRX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $WGRX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Fell Donald G.

    3 - Wellgistics Health, Inc. (0002030763) (Issuer)

    10/21/25 3:04:46 PM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    SEC Form 3 filed by new insider Lee Steven Dale

    3 - Wellgistics Health, Inc. (0002030763) (Issuer)

    10/14/25 4:45:31 PM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    Director Peterson Michael L gave a grant of 200,000 shares, decreasing direct ownership by 50% to 200,000 units (SEC Form 4)

    4 - Wellgistics Health, Inc. (0002030763) (Issuer)

    7/8/25 5:15:29 PM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    $WGRX
    SEC Filings

    View All

    Wellgistics Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Wellgistics Health, Inc. (0002030763) (Filer)

    10/22/25 8:41:18 AM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    SEC Form PRE 14C filed by Wellgistics Health Inc.

    PRE 14C - Wellgistics Health, Inc. (0002030763) (Filer)

    10/21/25 5:17:45 PM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    Wellgistics Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Wellgistics Health, Inc. (0002030763) (Filer)

    10/17/25 4:58:28 PM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    $WGRX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DataVault AI and Wellgistics Health Announce Plans for PharmacyChain™ to Implement Manufacturer-to-Patient Blockchain-enabled Smart Contracts for the Prescription Drug Industry to Improve Efficiency and Patient Outcomes

    BEAVERTON, Ore., Oct. 22, 2025 (GLOBE NEWSWIRE) -- via IBN -- DataVault AI, Inc. ("DataVault") (NASDAQ:DVLT), leading the way in AI data experience, valuation, and monetization, and Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the two companies have entered into a non-binding letter of intent to implement manufacturer-to-patient blockchain-enabled smart contracts ("PharmacyChain™") into Wellgistics proprietary Technology and Physical infrastructure for the prescription drug industry. The goal of the partnership will be to seek to fully digitize t

    10/22/25 6:05:00 AM ET
    $DVLT
    $WGRX
    Semiconductors
    Technology
    Other Pharmaceuticals
    Health Care

    WGRX CEO Brian Norton to Go Live on Floorstocks YouTube — Unfiltered Market Talk at 1 PM EST

    NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ:WGRX), a growing force in pharmaceutical distribution and healthcare technology, will appear live on YouTube via the Floorstocks channel (@floorstocks) this Tuesday, July 22 at 1:00 PM EST. CEO Brian Norton will participate in an unfiltered discussion covering WGRX's recent momentum, stock performance, market outlook, and the company's strategy ahead. Floorstocks—the platform known for amplifying rising public companies—will host this live session, providing retail investors direct engagement. Why Tune In? Hear firsthand insight from CEO Brian Norton on the company's latest developmentsDeep dive into WGRX

    7/22/25 4:27:53 AM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    Floorstocks Releases Exclusive Nasdaq MarketSite Interview with Wellgistics Health Inc. (NASDAQ: WGRX)

    NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Floorstocks, a financial media platform with over 1.2 million active retail investors, has released an exclusive CEO interview filmed at the Nasdaq MarketSite with Brian Norton, CEO of Wellgistics Health Inc. (NASDAQ:WGRX). The full interview is now available on YouTube and Floorstocks.com, offering investors a front-row look at one of healthcare's most disruptive emerging growth companies. Watch the full interview on YouTube:https://youtu.be/gJJlbqd7Mv8 Also streaming at Floorstocks.com:https://www.floorstocks.com Hosted by market veteran Kenneth Polcari, the interview unpacks how Wellgistics is modernizing the $600+ billion U.S. prescription

    7/10/25 11:46:00 AM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    $WGRX
    Financials

    Live finance-specific insights

    View All

    Wellgistics Health Secures $50M ELOC facility for XRP Treasury Reserve & Real-Time Payments Infrastructure and other general ops

    Tampa, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ:WGRX), a technology-first pharmaceutical distribution and healthcare infrastructure company, today announced a new initiative to pioneer the use of XRP, a blockchain-based digital asset, as both a treasury reserve and a real-time payments infrastructure-which management believes, upon successful commercialization, would make Wellgistics among the first publicly traded healthcare companies to deploy XRP in this manner. This XRP payment initiative is supported by Wellgistics Health's $50 million Equity Line of Credit (ELOC), the proceeds of which may be utilized to further develop and unlock programmable liquidity

    5/8/25 9:00:00 AM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    Wellgistics Health Secures $50M Credit Facility and Launches XRP-Powered Payment Initiative

    Tampa, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ:WGRX), a technology-first pharmaceutical distribution and healthcare infrastructure company, today announced a new initiative to pioneer the use of XRP, a blockchain-based digital asset, as both a treasury reserve and a real-time payments infrastructure-which management believes, upon successful commercialization, would make Wellgistics among the first publicly traded healthcare companies to deploy XRP in this manner. This XRP payment initiative is supported by Wellgistics Health's $50 million Equity Line of Credit (ELOC), the proceeds of which may be utilized to further develop and unlock programmable liquidity

    5/8/25 7:05:00 AM ET
    $WGRX
    Other Pharmaceuticals
    Health Care